Comparalve Study of Octreotide and Loperamide in the Treatmentof 5-Fluorouracial-induced Diarrhea
Shimin Wen
Abstract
Shimin Wen
Abstract
Objective:To observe the complete response rate of diarrhea and median time of response to octreotide and loperamide in 5-Fluorouracial-induced diarrhea.Method:30 cases patients with 5-Fluorouracial-induced diarrhea are divided into octreotide group(OCT group 14) and loperamide group(LOP group 16)respectively.Result:The complete response rate of diarrhea is 78.57% (11/14) in OCT group and 43.75% (7/16) in LOP group.There was satatistically significant difference beaween these twe groups(P0.05),The midian time of complete response was 3 days in OCT group and 6.5 days in LOP group.Conclusion:Octveotide was more effect than loperamide in 5- Fluorouracial-induced diarrhea,and may improve diarrhea in shirt period.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the complete response rate of diarrhea and median time of response to octreotide and loperamide in 5-Fluorouracial-induced diarrhea.Method:30 cases patients with 5-Fluorouracial-induced diarrhea are divided into octreotide group(OCT group 14) and loperamide group(LOP group 16)respectively.Result:The complete response rate of diarrhea is 78.57% (11/14) in OCT group and 43.75% (7/16) in LOP group.There was satatistically significant difference beaween these twe groups(P0.05),The midian time of complete response was 3 days in OCT group and 6.5 days in LOP group.Conclusion:Octveotide was more effect than loperamide in 5- Fluorouracial-induced diarrhea,and may improve diarrhea in shirt period.
Key concepts: Loperamide, Medicine, Diarrhea, Octreotide, Gastroenterology, Internal medicine, Significant difference, Somatostatin